3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
5
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Solitary Fibrous Tumor, Pleural
1
Pleural Effusion, Malignant
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Interventions
Pemetrexed
13
Cisplatin
12
Carboplatin
12
Drug Therapy
10
Gemcitabine
8
Gefitinib
8
Docetaxel
8
camrelizumab
5
apatinib
5
Radiotherapy
5
Paclitaxel
5
Nivolumab
5
Irinotecan
5
Erlotinib Hydrochloride
5
Endostatins
5
tislelizumab
4
pembrolizumab
4
endostar protein
4
Simvastatin
4
Bevacizumab
4
anlotinib
3
Platinum Compounds
3
Immune Checkpoint Inhibitors
3
Etoposide
3
toripalimab
2
surufatinib
2
olaparib
2
durvalumab
2
atezolizumab
2
Topotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Talc
×
Thoracic
×
Clear all
NCT00821860
2013-06-28
MesoVATS
Papworth Hospital NHS Foundation Trust
Phase 3
Completed
196 enrolled